Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ELI LILLY & Co Director's Dealing 2016

Jan 29, 2016

29745_dirs_2016-01-28_e1cd07b2-80f6-4f6a-82c7-7fe48fbe3144.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LILLY ELI & CO (LLY)
CIK: 0000059478
Period of Report: 2016-01-26

Reporting Person: Lundberg Jan M (EVP,Science&Tech and Pres. LRL)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2016-01-26 Common Stock A 29081 $81.96 Acquired 106501 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2016-01-26 Restricted Stock Unit $ A 15366 Acquired 2017-02-01 Common Stock (15366.0) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 1030 Indirect

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.